InvestorsHub Logo
Followers 829
Posts 119615
Boards Moderated 14
Alias Born 09/05/2002

Re: semi_infinite post# 1804

Thursday, 09/26/2019 2:50:07 PM

Thursday, September 26, 2019 2:50:07 PM

Post# of 2958

…given so-so results in RSV and HBV (if recollection serves).

ENTA hasn’t yet had any clinical results in HBV.

In RSV, there isn’t any competition for a treatment (rather than a vaccine), so even a “so-so” drug in an absolute sense could be a big commercial success.

In short, ENTA’s pipeline definitely has value.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News